275 related articles for article (PubMed ID: 32359162)
1. Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
Choueiri TK; Atkins MB; Bakouny Z; Carlo MI; Drake CG; Jonasch E; Kapur P; Lewis B; Linehan WM; Mitchell MJ; Pal SK; Pels K; Poteat S; Rathmell WK; Rini BI; Signoretti S; Tannir N; Uzzo R; Wood CG; Hammers HJ
J Natl Cancer Inst; 2021 Mar; 113(3):234-243. PubMed ID: 32359162
[TBL] [Abstract][Full Text] [Related]
2. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
Choueiri TK; Albiges L; Atkins MB; Bakouny Z; Bratslavsky G; Braun DA; Haas NB; Haanen JBAG; Hakimi AA; Jewett MAS; Jonasch E; Kaelin WG; Kapur P; Labaki C; Lewis B; McDermott DF; Pal SK; Pels K; Poteat S; Powles T; Rathmell WK; Rini BI; Signoretti S; Tannir NM; Uzzo RG; Hammers HJ
Clin Cancer Res; 2022 Mar; 28(5):831-839. PubMed ID: 34965942
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
4. The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023.
Choueiri TK; Pal SK; Lewis B; Poteat S; Pels K; Hammers H
Oncologist; 2024 Feb; 29(2):91-98. PubMed ID: 38048064
[TBL] [Abstract][Full Text] [Related]
5. State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy Era.
Bakouny Z; Flippot R; Braun DA; Lalani AA; Choueiri TK
Eur Urol Focus; 2020 Jan; 6(1):37-40. PubMed ID: 30827939
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Strategies for Hereditary Kidney Cancer.
Sidana A; Srinivasan R
Curr Oncol Rep; 2016 Aug; 18(8):50. PubMed ID: 27325049
[TBL] [Abstract][Full Text] [Related]
7. Towards individualized therapy for metastatic renal cell carcinoma.
Kotecha RR; Motzer RJ; Voss MH
Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
[TBL] [Abstract][Full Text] [Related]
8. Update on the biology and management of renal cell carcinoma.
Dutcher JP
J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223
[TBL] [Abstract][Full Text] [Related]
9. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma.
Savage PD
Curr Opin Oncol; 1994 May; 6(3):301-7. PubMed ID: 8080860
[TBL] [Abstract][Full Text] [Related]
11. Designing clinical trials for kidney cancer based on newly developed prognostic and predictive tools.
Cho D; McDermott D; Atkins M
Curr Urol Rep; 2006 Jan; 7(1):8-15. PubMed ID: 16480663
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in immunotherapy for kidney cancer.
Ball MW; Allaf ME; Drake CG
Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.
Vuong L; Kotecha RR; Voss MH; Hakimi AA
Cancer Discov; 2019 Oct; 9(10):1349-1357. PubMed ID: 31527133
[TBL] [Abstract][Full Text] [Related]
14. Management of renal cell carcinoma in young patients and patients with hereditary syndromes.
Leung C; Pan S; Shuch B
Curr Opin Urol; 2016 Sep; 26(5):396-404. PubMed ID: 27387961
[TBL] [Abstract][Full Text] [Related]
15. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients.
Ito T; Kutikov A
Nat Rev Urol; 2015 Feb; 12(2):69-70. PubMed ID: 25600094
[No Abstract] [Full Text] [Related]
16. Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma.
Adashek JJ; Salgia MM; Posadas EM; Figlin RA; Gong J
Clin Genitourin Cancer; 2019 Jun; 17(3):e454-e460. PubMed ID: 30733185
[TBL] [Abstract][Full Text] [Related]
17. [Medical therapies for locally advanced/metastatic kidney cancer].
Afrit M; Yahyaoui Y; Bouzouita A; Hantous S; Labidi S; Chebil M; Ben Miled K; Escudier B; Boussen H
Presse Med; 2015 Feb; 44(2):135-43. PubMed ID: 25535168
[TBL] [Abstract][Full Text] [Related]
18. Kidney cancer: past, present, and future.
Novick AC
Urol Oncol; 2007; 25(3):188-95. PubMed ID: 17483014
[No Abstract] [Full Text] [Related]
19. Immunotherapy in kidney cancer: the past, present, and future.
Hammers H
Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
[TBL] [Abstract][Full Text] [Related]
20. Renal cancer: Genetic directed therapy.
Loughlin KR
Urol Oncol; 2009; 27(2):130. PubMed ID: 19285229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
